![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 22, 20079-20086, May 31, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The androgen receptor (AR) is a member of the
nuclear receptor superfamily. Sequences within the large amino-terminal
domain of the receptor have been shown to be important for
transactivation and protein-protein interactions; however, little is
known about the structure and folding of this region. In the present
study we show that a 344-amino acid polypeptide representing the main determinants for transactivation has the propensity to form
Conformational Analysis of the Androgen Receptor Amino-terminal
Domain Involved in Transactivation
INFLUENCE OF STRUCTURE-STABILIZING SOLUTES AND
PROTEIN-PROTEIN INTERACTIONS*
§,
,
Department of Molecular and Cell Biology,
Institute of Medical Sciences, University of Aberdeen,
Foresterhill, Aberdeen AB25 2ZD, Scotland, United Kingdom and
¶ IBLS Division of Biochemistry and Molecular Biology, Joseph
Black Building, University of Glasgow,
Glasgow G12 8QQ, Scotland, United Kingdom
-helical structure and that mutations which disrupt putative helical regions alter conformation. Folding of the AR was observed in the presence of
the helix-stabilizing solvent trifluoroethanol and the natural osmolyte
trimethylamine N-oxide (TMAO). TMAO resulted in the
movement of two tryptophan residues to a less solvent-exposed
environment and the formation of secondary/tertiary structure resistant
to protease cleavage. Critically, binding to the RAP74 subunit of the
general transcription factor TFIIF resulted in extensive protease resistance, consistent with induced folding of the receptor
transactivation domain. These data indicate that this region of the AR
is structurally flexible and folds into a stable conformation upon
interactions with a component of the general transcription machinery.
*
This work was supported in part by Biotechnology and
Biological Sciences Research Council Grant 1/C10407.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
44-1224-273107; Fax: 44-1224-273144; E-mail:
iain.mcewan@abdn.ac.uk.
This article has been cited by other articles:
![]() |
N. P. Mahajan, Y. Liu, S. Majumder, M. R. Warren, C. E. Parker, J. L. Mohler, H. S. Earp, and Y. E. Whang Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation PNAS, May 15, 2007; 104(20): 8438 - 8443. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tung, H. Abdel-Hafiz, T. Shen, D. M. E. Harvell, L. K. Nitao, J. K. Richer, C. A. Sartorius, G. S. Takimoto, and K. B. Horwitz Progesterone Receptors (PR)-B and -A Regulate Transcription by Different Mechanisms: AF-3 Exerts Regulatory Control over Coactivator Binding to PR-B Mol. Endocrinol., November 1, 2006; 20(11): 2656 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tian, M. A. Mahajan, C. T. Wong, I. Habeos, and H. H. Samuels The N-Terminal A/B Domain of the Thyroid Hormone Receptor-{beta}2 Isoform Influences Ligand-Dependent Recruitment of Coactivators to the Ligand-Binding Domain Mol. Endocrinol., September 1, 2006; 20(9): 2036 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Choudhry, A. Ball, and I. J. McEwan The Role of the General Transcription Factor IIF in Androgen Receptor-Dependent Transcription Mol. Endocrinol., September 1, 2006; 20(9): 2052 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Callewaert, N. Van Tilborgh, and F. Claessens Interplay between Two Hormone-Independent Activation Domains in the Androgen Receptor Cancer Res., January 1, 2006; 66(1): 543 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wardell, S. C. Kwok, L. Sherman, R. S. Hodges, and D. P. Edwards Regulation of the Amino-Terminal Transcription Activation Domain of Progesterone Receptor by a Cofactor-Induced Protein Folding Mechanism Mol. Cell. Biol., October 15, 2005; 25(20): 8792 - 8808. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, C. N. Cavasotto, T. Cardozo, S. Ha, T. Dang, S. S. Taneja, S. K. Logan, and M. J. Garabedian Androgen Receptor Mutations Identified in Prostate Cancer and Androgen Insensitivity Syndrome Display Aberrant ART-27 Coactivator Function Mol. Endocrinol., September 1, 2005; 19(9): 2273 - 2282. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brodie and I. J McEwan Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding J. Mol. Endocrinol., June 1, 2005; 34(3): 603 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Petrescu, R. Hertz, J. Bar-Tana, F. Schroeder, and A. B. Kier Role of Regulatory F-domain in Hepatocyte Nuclear Factor-4{alpha} Ligand Specificity J. Biol. Chem., April 29, 2005; 280(17): 16714 - 16727. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Han, G. Buchanan, M. Ittmann, J. M. Harris, X. Yu, F. J. DeMayo, W. Tilley, and N. M. Greenberg Mutation of the androgen receptor causes oncogenic transformation of the prostate PNAS, January 25, 2005; 102(4): 1151 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, D. E. Volk, J. Li, J. C. Lee, D. G. Gorenstein, and E. B. Thompson TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain PNAS, November 23, 2004; 101(47): 16425 - 16430. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Buchanan, M. Yang, A. Cheong, J. M. Harris, R. A. Irvine, P. F. Lambert, N. L. Moore, M. Raynor, P. J. Neufing, G. A. Coetzee, et al. Structural and functional consequences of glutamine tract variation in the androgen receptor Hum. Mol. Genet., August 15, 2004; 13(16): 1677 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. He, S. Bai, A. T. Hnat, R. I. Kalman, J. T. Minges, C. Patterson, and E. M. Wilson An Androgen Receptor NH2-terminal Conserved Motif Interacts with the COOH Terminus of the Hsp70-interacting Protein (CHIP) J. Biol. Chem., July 16, 2004; 279(29): 30643 - 30653. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Warnmark, E. Treuter, A. P. H. Wright, and J.-A. Gustafsson Activation Functions 1 and 2 of Nuclear Receptors: Molecular Strategies for Transcriptional Activation Mol. Endocrinol., October 1, 2003; 17(10): 1901 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar and E. B. Thompson Transactivation Functions of the N-Terminal Domains of Nuclear Hormone Receptors: Protein Folding and Coactivator Interactions Mol. Endocrinol., January 1, 2003; 17(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reid, I. Murray, K. Watt, R. Betney, and I. J. McEwan The Androgen Receptor Interacts with Multiple Regions of the Large Subunit of General Transcription Factor TFIIF J. Biol. Chem., October 18, 2002; 277(43): 41247 - 41253. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |